A carregar...
Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis
The development of tumor lysis syndrome (TLS) in association with treatment for myeloproliferative neoplasms (MPNs) is relatively rare. We herein present the case of a post-polycythemia vera (PV) myelofibrosis patient with massive splenomegaly who developed laboratory TLS after treatment with ruxoli...
Na minha lista:
Publicado no: | Intern Med |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
The Japanese Society of Internal Medicine
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635310/ https://ncbi.nlm.nih.gov/pubmed/28794380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8706-16 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|